申请人:UNIBIOSCREEN SA
公开号:WO2009033505A1
公开(公告)日:2009-03-19
The present invention relates to new cardiotonic steroids and their use in the treatment of cancer, in particular to compounds of Formula (I), stereoisomers, tautomers, racemates, prodrugs, metabolites, or a pharmaceutically acceptable salts, hydrates, or solvates thereof, wherein R1, R2, R3, R4, and R5 have the same meaning as that defined in the claims. The present invention also relates to compositions, in particular pharmaceuticals, comprising such compounds, and to uses of such compounds in the treatment and prophylaxis of cancer.
本发明涉及新的心脏强效甾体类化合物及其在癌症治疗中的应用,特别是涉及式(I)的化合物、立体异构体、互变异构体、外消旋体、前药、代谢物或药物可接受的盐、水合物或溶剂化物,其中R1、R2、R3、R4和R5的含义与所述权利要求所定义的相同。本发明还涉及包含此类化合物的组合物,特别是制药组合物,以及在癌症治疗和预防中使用此类化合物的方法。